DrugPatentWatch Database Preview
PROGLYCEM Drug Profile
or, see our see our flat-rate plans
Which patents cover Proglycem, and what generic alternatives are available?
The generic ingredient in PROGLYCEM is diazoxide. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diazoxide profile page.
Summary for PROGLYCEM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 69 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,002 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROGLYCEM at DailyMed |
Medical Subject Heading (MeSH) Categories for PROGLYCEM
Synonyms for PROGLYCEM
| 2270-EP2281815A1 |
| 2270-EP2295550A2 |
| 2270-EP2301933A1 |
| 2270-EP2308838A1 |
| 2270-EP2311827A1 |
| 2H-1,2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide |
| 2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide |
| 2H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-, 1,1-dioxide |
| 2H-1,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide |
| 32273-EP2281815A1 |
| 32273-EP2298415A1 |
| 32273-EP2301933A1 |
| 32273-EP2305640A2 |
| 32273-EP2311827A1 |
| 364-98-7 |
| 364D987 |
| 4H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide |
| 7-?CHLORO-?3-?METHYL-?1,?1-?DIOXIDE-?2H-?1,?2,?4-?BENZOTHIADIAZINE |
| 7-chloranyl-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-1,2,4-benzothiadiazine,1,1-dioxide |
| 7-Chloro-3-methyl-1lambda~4~,2,4-benzothiadiazin-1-ol 1-oxide |
| 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide |
| 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine1,1-dioxide |
| 7-Chloro-3-methyl-2H-1,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-2H-1?^{6},2,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-2H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-4H-1 |
| 7-chloro-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-4H-1|E?,2,4-benzothiadiazine-1,1-dione |
| 7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide |
| 7-chloro-3-methyl-4H-1$l;{6},2,4-benzothiadiazine-1,1-dione |
| 7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide |
| 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido |
| 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido [Italian] |
| A823275 |
| AC1L1EZN |
| ACM364987 |
| AKOS015896340 |
| AKOS024458715 |
| AN-23421 |
| AOB5782 |
| Aroglycem |
| B6526 |
| BDBM86248 |
| BG0437 |
| Bio1_000036 |
| Bio1_000525 |
| Bio1_001014 |
| Bio2_000027 |
| Bio2_000507 |
| BPBio1_000016 |
| BRD-K73109821-001-05-2 |
| BSPBio_000014 |
| BSPBio_001307 |
| BSPBio_002290 |
| C-13401 |
| C06949 |
| C8H7ClN2O2S |
| CAS_364-98-7 |
| CAS-364-98-7 |
| CBiol_001750 |
| CC-26456 |
| CCG-101062 |
| CCG-204497 |
| CHEBI:4495 |
| CHEMBL1518123 |
| CHEMBL181 |
| CPD000058392 |
| CS-4745 |
| D 9035 |
| D00294 |
| D07WEP |
| D5402 |
| DB01119 |
| Diazossido |
| Diazossido [DCIT] |
| Diazossido [Italian] |
| diazoxide |
| Diazoxide (JAN/USP/INN) |
| Diazoxide [USAN:INN:BAN] |
| Diazoxide [USAN:USP:INN:BAN:JAN] |
| Diazoxide, European Pharmacopoeia (EP) Reference Standard |
| Diazoxide, United States Pharmacopeia (USP) Reference Standard |
| Diazoxido |
| Diazoxido [INN-Spanish] |
| Diazoxidum |
| Diazoxidum [INN-Latin] |
| Dizoxide |
| DR000502 |
| DSSTox_CID_2914 |
| DSSTox_GSID_22914 |
| DSSTox_RID_76786 |
| DTXSID7022914 |
| EINECS 206-668-1 |
| EN300-122611 |
| EU-0100404 |
| Eudemine |
| Eudemine injection |
| FCH1327708 |
| FT-0603087 |
| GDLBFKVLRPITMI-UHFFFAOYSA-N |
| GTPL2409 |
| HE338475 |
| HMS1361B09 |
| HMS1568A16 |
| HMS1791B09 |
| HMS1922L22 |
| HMS1989B09 |
| HMS2051P20 |
| HMS2089L04 |
| HMS2093N12 |
| HMS2095A16 |
| HMS2234B23 |
| HMS3261A10 |
| HMS3267I11 |
| HMS3371L13 |
| HMS3393P20 |
| HMS3402B09 |
| HY-B1140 |
| Hyperstat |
| Hyperstat (TN) |
| Hypertonalum |
| I06-2041 |
| IDI1_033777 |
| KBio2_000027 |
| KBio2_002595 |
| KBio2_005163 |
| KBio3_000053 |
| KBio3_000054 |
| KBio3_001510 |
| KBioGR_000027 |
| KBioGR_001776 |
| KBioSS_000027 |
| KC-115 |
| KS-000010A1 |
| KS-1444 |
| Lopac-D-9035 |
| Lopac0_000404 |
| LP00404 |
| LS-40410 |
| MCULE-5031397425 |
| MFCD00078578 |
| MLS000028459 |
| MLS001076071 |
| MLS001424164 |
| MolPort-003-666-772 |
| MolPort-003-941-186 |
| Mutabase |
| NC00312 |
| NCGC00015380-01 |
| NCGC00015380-02 |
| NCGC00015380-03 |
| NCGC00015380-04 |
| NCGC00015380-05 |
| NCGC00015380-06 |
| NCGC00015380-07 |
| NCGC00015380-08 |
| NCGC00015380-09 |
| NCGC00015380-10 |
| NCGC00015380-11 |
| NCGC00015380-12 |
| NCGC00015380-13 |
| NCGC00022882-03 |
| NCGC00024907-01 |
| NCGC00024907-02 |
| NCGC00024907-03 |
| NCGC00024907-04 |
| NCGC00024907-05 |
| NCGC00024907-06 |
| NCGC00024907-07 |
| NCGC00024907-08 |
| NCGC00261089-01 |
| NSC 64198 |
| NSC 76130 |
| NSC_3019 |
| NSC-64198 |
| NSC-759574 |
| NSC-76130 |
| NSC64198 |
| NSC759574 |
| NSC76130 |
| O5CB12L4FN |
| Opera_ID_608 |
| Pharmakon1600-02300206 |
| Prestwick_163 |
| Prestwick0_000087 |
| Prestwick1_000087 |
| Prestwick2_000087 |
| Prestwick3_000087 |
| Proglicem |
| s4630 |
| SAM001246872 |
| SC-83321 |
| Sch 6783 |
| Sch-6783 |
| SCHEMBL41254 |
| SMR000058392 |
| SPBio_001953 |
| SPECTRUM2300206 |
| Spectrum3_000735 |
| Spectrum4_001248 |
| SRG 95213 |
| SRG-95213 |
| Tocris-0964 |
| Tox21_110132 |
| Tox21_110132_1 |
| Tox21_500404 |
| UNII-O5CB12L4FN |
| VU0239714-6 |
| Z3125 |
| ZINC3872277 |
US Patents and Regulatory Information for PROGLYCEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Teva Branded Pharm | PROGLYCEM | diazoxide | SUSPENSION;ORAL | 017453-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
